An international study found the antiviral combination of tenofovir and emtricitabine (
Truvada) was most effective in treating younger adult hepatitis
B patients with high viral load
and normal ALT levels.
Doctors historically have not treated this group because there appeared to be no sign of liver damage. However, doctors now know that high viral loads may increase patients’ risk of liver damage and cancer as they age, despite their normal ALT levels.